Treace Medical Concepts (TMCI) Non-Current Debt (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Non-Current Debt for 7 consecutive years, with $56.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Debt rose 4.84% year-over-year to $56.0 million; the trailing twelve-month figure through Jun 2026 stood at $56.0 million (up 4.84% YoY), and the FY2025 full-year result was $55.6 million, up 4.27% from the prior year.
• Non-Current Debt held at $56.0 million in Q2 2026 per TMCI's latest filing, from $55.8 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $56.0 million in Q2 2026 and bottomed at $29.4 million in Q1 2022.
• Historically, Non-Current Debt has averaged $52.2 million across 5 years, with a median of $53.1 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Non-Current Debt soared 79.53% in 2022, then increased 0.56% in 2025.
• Over 5 years, Non-Current Debt stood at $52.7 million in 2022, then advanced by 0.56% to $53.0 million in 2023, then advanced by 0.56% to $53.3 million in 2024, then grew by 4.27% to $55.6 million in 2025, then gained by 0.83% to $56.0 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $56.0 million, $55.8 million, and $55.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.